Clinical Trial Update: Moxifloxacin i.v. in the Treatment of Complicated Intra-Abdominal Infection (cIAI)

View source ↗

Summary

A completed clinical trial assessed intravenous moxifloxacin for complicated intra-abdominal infection, including secondary peritonitis and intra-abdominal absc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intra-abdominal Abscess
• Peritonitis

Drugs mentioned

• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Bayer | Conditions: Secondary Peritonitis, Abscess, Intra-Abdominal | Status: COMPLETED